Simultaneous TAVR and EVAR may be a viable therapeutic option for surgical high-risk patients with severe aortic regurgitation and a giant abdominal aortic aneurysm.
Does simultaneous TAVR and EVAR provide a viable therapeutic option in surgical high-risk patients with concurrent abdominal aortic aneurysm and severe aortic valve disease?
Simultaneous TAVR and EVAR may be a viable therapeutic strategy for surgical high-risk patients presenting with both severe aortic regurgitation and a giant abdominal aortic aneurysm.
Absolute Event Rate: 0% vs 0%
For surgical high-risk patients with concurrent abdominal aortic aneurysm and severe aortic valve disease, the simultaneous implementation of TAVR and endovascular aneurysm repair may represent a viable therapeutic option.
He et al. (Sun,) reported a other. Simultaneous TAVR and EVAR may be a viable therapeutic option for surgical high-risk patients with severe aortic regurgitation and a giant abdominal aortic aneurysm.